Hideki Garren's Net Worth
$1.62 Million
Who is Hideki Garren?
Hideki Garren has an estimated net worth of $1.62 Million. This is based on reported shares across multiple companies, which include PROTHENA CORP PUBLIC LTD CO, and Coya Therapeutics, Inc..
SEC CIK
Hideki Garren's CIK is 0001854126
Past Insider Trading and Trends
2023 was Hideki Garren's most active year for acquiring shares with 9 total transactions. Hideki Garren's most active month to acquire stocks was the month of December. 2023 was Hideki Garren's most active year for disposing of shares, totalling 19 transactions. Hideki Garren's most active month to dispose stocks was the month of May. 2023 saw Hideki Garren paying a total of $747,000.00 for 81,000 shares, this is the most they've acquired in one year. In 2023 Hideki Garren cashed out on 60,000 shares for a total of $1,833,404.28, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
PROTHENA CORP PUBLIC LTD CO (PRTA) Snapshot price: $20.33
Chief Medical OfficerHideki Garren used to own units in Ordinary Shares, par value $0.01 per share but no longer holds any shares there. From 2021 to 2024 Hideki Garren acquired a total of 58,000 shares in PROTHENA CORP PUBLIC LTD CO at a cost of $1,444,200.00, Hideki also disposed a total of 58,000 shares of PROTHENA CORP PUBLIC LTD CO equalling to $3,056,698.90.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
|
—
|
0
|
$40.19 | -$61,152.20 |
0
|
Sep 13
| |||
Form 4
|
—
|
0
|
$41.82 | -$67,680.03 |
0
|
Aug 16
| |||
Form 4
|
—
|
0
|
$46.21 | -$85,226.61 |
0
|
Jul 12
| |||
Form 4
|
—
|
0
|
$49.45 | -$359,952.10 |
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
$49.56 | -$230,257.74 |
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
$36.66 | -$282,135.60 |
0
|
Scheduled
|
Mar 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
|
—
|
0
|
$43.71 | -$150,440.00 |
0
|
Scheduled
|
Dec 1
| ||
Form 4
|
—
|
0
|
$43.40 | -$147,974.62 |
0
|
Scheduled
|
Nov 1
| ||
Form 4
|
—
|
0
|
$42.90 | -$144,000.00 |
0
|
Scheduled
|
Oct 3
| ||
Form 4
|
—
|
0
|
$27.45 | -$20,400.00 |
0
|
Scheduled
|
Sep 15
| ||
Form 4
|
—
|
0
|
$27.71 | -$22,480.00 |
0
|
Scheduled
|
Aug 1
| ||
Form 4
|
—
|
0
|
$27.45 | -$40,800.00 |
0
|
Scheduled
|
Jul 6
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Coya Therapeutics, Inc. (COYA) Snapshot price: $6.14
InvestorHideki Garren owns 2,000 units of Common Stock, par value $0.0001 per share which is worth $12,280.00. In the year 2023 Hideki Garren acquired a total of 2,000 shares in Coya Therapeutics, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
∞
| 2K |
—
|
—
| 2K |
Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||